Instrument Inactif

Autres langues BioSpecifics Technologies Corp.

Actions

BSTC

US0909311062

Recherche biotechnologique et médicale

Autres langues

23/04/24	Endo International plc Emerged from Bankruptcy
22/03/24	Fourth Amended Joint Reorganization Plan Approved for Endo International plc
18/03/24	Fourth Amended Joint Reorganization Plan Filed by Endo International plc
20/02/24	Third Amended Joint Reorganization Plan and Disclosure Statement Filed by Endo International plc
25/01/24	Motion for Exclusivity Period Extension Approved For Endo International plc
12/01/24	Combined Hearing for Disclosure Statement and Plan Approved for Endo International plc
09/01/24	Second Amended Joint Reorganization Plan and Disclosure Statement Filed by Endo International plc
05/01/24	First Amended Reorganization Plan and Disclosure Statement Filed by Endo International plc
19/12/23	Joint Reorganization Plan and Disclosure Statement Filed by Endo International plc
16/11/23	Third Motion for Exclusivity Period Extension Approved For Endo International plc
31/07/23	Second Motion for Exclusivity Period Extension Approved For Endo International plc
25/05/23	Two Affiliate Companies Joined Endo International plc Bankruptcy
03/04/23	First Motion for Exclusivity Period Extension Approved For Endo International plc
14/12/22	First Motion for Exclusivity Period Extension Filed by Endo International plc
23/11/22	Motion for Asset Sale Filed by Endo International plc
27/10/22	Motion for Asset Sale Approved for Endo International plc
22/09/22	Motion for Asset Sale Filed by Endo International plc
02/09/22	Motion for De Minimis Assets Sale Filed by Endo International plc
17/08/22	Motion for Joint Administration Approved for Endo International plc
16/08/22	Motion for Joint Administration Filed by Endo International plc
16/08/22	Endo International plc Filed for Bankruptcy
02/12/20	BioSpecifics Technologies Corp. Announces Management Changes
02/12/20	BIOSPECIFICS TECHNOLOGIES CORP : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)
02/12/20	BioSpecifics Technologies Corp.(NasdaqGM:BSTC) dropped from S&P Global BMI Index
02/12/20	BioSpecifics Technologies Corp.(NasdaqGM:BSTC) dropped from S&P TMI Index